Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REaCT-NSQIP: No Preparation vs Oral Antibiotics in Elective Colon Surgery
NCT03663504Phase 4Active, not recruiting
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Oct 2018
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of neomycin, metronidazole in surgical site infection (SSI), sponsored by Ottawa Hospital Research Institute. Started Oct 2018; status: active, not recruiting.
02
Drugs
neomycinmetronidazole
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03663504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03663504.